• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Galactose-1-phosphate uridyltransferase dried blood spot quality control materials for newborn screening tests.用于新生儿筛查试验的1-磷酸半乳糖尿苷酰转移酶干血斑质量控制材料。
Clin Biochem. 2015 Apr;48(6):437-42. doi: 10.1016/j.clinbiochem.2014.12.009. Epub 2014 Dec 18.
2
The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States.美国推荐的新生儿筛查疾病中干血斑标志物的稳定性。
Clin Biochem. 2011 Dec;44(17-18):1445-50. doi: 10.1016/j.clinbiochem.2011.09.010. Epub 2011 Sep 21.
3
Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.多重串联质谱法用于新生儿 X 连锁肾上腺脑白质营养不良、生物素酶缺乏症和半乳糖血症的筛查,具有灵活检测其他酶检测和生物标志物的能力。
Mol Genet Metab. 2018 Jun;124(2):101-108. doi: 10.1016/j.ymgme.2018.03.012. Epub 2018 Mar 29.
4
Quantitative Beutler test for newborn mass screening of galactosemia using a fluorometric microplate reader.使用荧光酶标仪进行新生儿半乳糖血症群体筛查的定量比尤特勒试验。
Clin Chem. 2000 Jun;46(6 Pt 1):806-10.
5
GALT Deficiency Galactosemia.GALT缺乏症(半乳糖血症)。
MCN Am J Matern Child Nurs. 2018 Jan/Feb;43(1):44-51. doi: 10.1097/NMC.0000000000000388.
6
Florida newborn screening for galactosemia.佛罗里达州对半乳糖血症进行新生儿筛查。
J Fla Med Assoc. 1991 Jun;78(6):369-71.
7
The preparation and storage of dried-blood spot quality control materials for lysosomal storage disease screening tests.溶酶体贮积病筛查试验用干血斑质量控制材料的制备和储存。
Clin Biochem. 2011 Jun;44(8-9):704-10. doi: 10.1016/j.clinbiochem.2011.02.014. Epub 2011 Mar 4.
8
Galactosemia: when is it a newborn screening emergency?半乳糖血症:何时属于新生儿筛查急症?
Mol Genet Metab. 2012 May;106(1):7-11. doi: 10.1016/j.ymgme.2012.03.007. Epub 2012 Mar 21.
9
Ultra fast and sensitive liquid chromatography tandem mass spectrometry based assay for galactose-1-phosphate uridylyltransferase and galactokinase deficiencies.基于超快速灵敏液相色谱串联质谱法的半乳糖-1-磷酸尿苷酰转移酶和半乳糖激酶缺乏症检测方法。
Mol Genet Metab. 2011 Jan;102(1):33-40. doi: 10.1016/j.ymgme.2010.08.018. Epub 2010 Sep 21.
10
Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach.新生儿半乳糖血症筛查:5 年数据回顾及改良报告方式审核
Clin Chem. 2010 Mar;56(3):437-44. doi: 10.1373/clinchem.2009.135947. Epub 2010 Jan 14.

引用本文的文献

1
Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors.因免疫反应性胰蛋白酶原水平低于项目临界值导致的囊性纤维化新生儿筛查漏诊病例:一项全国性危险因素调查
Int J Neonatal Screen. 2022 Oct 27;8(4):58. doi: 10.3390/ijns8040058.
2
Transferrin Isoforms, Old but New Biomarkers in Hereditary Fructose Intolerance.转铁蛋白异构体,遗传性果糖不耐受中古老却崭新的生物标志物
J Clin Med. 2021 Jun 30;10(13):2932. doi: 10.3390/jcm10132932.
3
Development of dried blood spot quality control materials for adenosine deaminase severe combined immunodeficiency and LC-MS/MS method for their characterization.用于腺苷脱氨酶严重联合免疫缺陷的干血斑质量控制材料的开发及其表征的液相色谱-串联质谱法。
Clin Mass Spectrom. 2020 Aug;17(4):4-11. doi: 10.1016/j.clinms.2020.07.002. Epub 2020 Jul 10.
4
Screening for galactosemia: is there a place for it?半乳糖血症筛查:有必要进行吗?
Int J Gen Med. 2019 May 23;12:193-205. doi: 10.2147/IJGM.S180706. eCollection 2019.
5
Glucose-6-phosphate dehydrogenase enzyme stability in filter paper dried blood spots.葡萄糖-6-磷酸脱氢酶在滤纸干血斑中的酶稳定性。
Clin Biochem. 2017 Oct;50(15):878-881. doi: 10.1016/j.clinbiochem.2017.05.003. Epub 2017 May 4.
6
The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five Year Experience Assuring Newborn Screening Laboratory Quality.美国疾病控制与预防中心的新生儿筛查质量保证项目:确保新生儿筛查实验室质量的35年经验
Int J Neonatal Screen. 2015;1(1):13-26. doi: 10.3390/ijns1010013.

本文引用的文献

1
Stabilities of hemoglobins A and S in dried blood spots stored under controlled conditions.血红蛋白 A 和 S 在干燥血斑中的稳定性研究,存储于可控条件下。
Clin Biochem. 2013 Aug;46(12):1089-1092. doi: 10.1016/j.clinbiochem.2013.05.043. Epub 2013 May 20.
2
The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States.美国推荐的新生儿筛查疾病中干血斑标志物的稳定性。
Clin Biochem. 2011 Dec;44(17-18):1445-50. doi: 10.1016/j.clinbiochem.2011.09.010. Epub 2011 Sep 21.
3
Multi-rule quality control for the age-related eye disease study.年龄相关性眼病研究的多规则质量控制
Stat Med. 2008 Sep 10;27(20):4094-106. doi: 10.1002/sim.3222.
4
National evaluation of US newborn screening system components.美国新生儿筛查系统组成部分的全国性评估。
Ment Retard Dev Disabil Res Rev. 2006;12(4):236-45. doi: 10.1002/mrdd.20124.
5
Newborn screening fact sheets.新生儿筛查情况说明书。
Pediatrics. 2006 Sep;118(3):e934-63. doi: 10.1542/peds.2006-1783.
6
Classical galactosaemia revisited.经典型半乳糖血症再探讨。
J Inherit Metab Dis. 2006 Aug;29(4):516-25. doi: 10.1007/s10545-006-0382-0. Epub 2006 Jul 11.
7
Newborn screening: toward a uniform screening panel and system.新生儿筛查:迈向统一的筛查项目和系统。
Genet Med. 2006 May;8 Suppl 1(Suppl 1):1S-252S. doi: 10.1097/01.gim.0000223891.82390.ad.
8
Newborn screening: toward a uniform screening panel and system--executive summary.新生儿筛查:迈向统一的筛查项目和系统——执行摘要
Pediatrics. 2006 May;117(5 Pt 2):S296-307. doi: 10.1542/peds.2005-2633I.
9
Observations on heat/humidity denaturation of enzymes in filter-paper blood spots from newborns.新生儿滤纸血斑中酶的热/湿度变性观察
Clin Chem. 2005 Jun;51(6):1060-2. doi: 10.1373/clinchem.2005.049270. Epub 2005 Apr 21.
10
A new test for 'sufficient homogeneity'.一种用于检测“充分同质性”的新测试。
Analyst. 2001 Aug;126(8):1414-7. doi: 10.1039/b103812p.

用于新生儿筛查试验的1-磷酸半乳糖尿苷酰转移酶干血斑质量控制材料。

Galactose-1-phosphate uridyltransferase dried blood spot quality control materials for newborn screening tests.

作者信息

Adam Barbara W, Flores Sharon R, Hou Yu, Allen Todd W, De Jesus Victor R

机构信息

Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA 30341, USA.

Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA 30341, USA.

出版信息

Clin Biochem. 2015 Apr;48(6):437-42. doi: 10.1016/j.clinbiochem.2014.12.009. Epub 2014 Dec 18.

DOI:10.1016/j.clinbiochem.2014.12.009
PMID:25528144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4547523/
Abstract

OBJECTIVES

We aimed to prepare dried-blood-spot (DBS) quality control (QC) materials for galactose-1-phosphate uridyltransferase (GALT), to evaluate their stability during storage and use, and to evaluate their performance in five DBS GALT test methods.

DESIGN AND METHODS

We prepared and characterized GALT-normal and GALT-deficient DBS materials and compared GALT activities in DBSs after predetermined storage intervals at controlled temperatures and humidities. External evaluators documented the suitability of the DBS QC materials for use in five GALT test methods.

RESULTS

GALT activity losses from DBSs stored in low (<30%) humidity for 14 days at 45°C, 35 days at 37°C, 91 days at room temperature, 182 days at 4°C, and 367 days at -20°C were 54%, 53%, 52% 23%, and 7% respectively. In paired DBSs stored in high humidity (>50%) for identical intervals, losses were: 45°C-68%; 37°C-79%; room temperature-72%, and 4°C-63%. GALT activities in DBSs stored at 4°C were stable throughout 19 excursions to room temperature. Twenty-five of 26 external evaluators, using five different GALT test methods, classified the GALT-deficient DBSs as "outside normal limits". All evaluators classified the GALT-normal DBSs as "within normal limits".

CONCLUSIONS

Most of the GALT activity loss from DBSs stored at elevated or room temperature was attributable to the effects of storage temperature. Most of the loss from DBSs stored at 4°C was attributable to the effects of elevated humidity. Loss from DBSs stored at -20°C was insignificant. The DBS materials were suitable for monitoring performance of all five GALT test methods.

摘要

目的

我们旨在制备用于1-磷酸半乳糖尿苷转移酶(GALT)的干血斑(DBS)质量控制(QC)材料,评估其在储存和使用过程中的稳定性,并评估其在五种DBS GALT检测方法中的性能。

设计与方法

我们制备并表征了GALT正常和GALT缺陷的DBS材料,并比较了在受控温度和湿度下经过预定储存时间后的DBS中GALT的活性。外部评估人员记录了DBS QC材料在五种GALT检测方法中的适用性。

结果

在45°C下低湿度(<30%)储存14天、37°C下储存35天、室温下储存91天、4°C下储存182天以及-20°C下储存367天的DBS中,GALT活性损失分别为54%、53%、52%、23%和7%。在相同时间间隔内高湿度(>50%)储存的配对DBS中,损失情况如下:45°C - 68%;37°C - 79%;室温 - 72%,4°C - 63%。在4°C储存的DBS在19次室温变动过程中GALT活性保持稳定。26名外部评估人员中的25名使用五种不同的GALT检测方法将GALT缺陷的DBS分类为“超出正常范围”。所有评估人员将GALT正常的DBS分类为“在正常范围内”。

结论

在高温或室温下储存的DBS中,大部分GALT活性损失归因于储存温度的影响。在4°C储存的DBS中,大部分损失归因于高湿度的影响。在-20°C储存的DBS损失不显著。这些DBS材料适用于监测所有五种GALT检测方法的性能。